Advanced company searchLink opens in new window

HEMAVANT SCIENCES HOLDINGS LIMITED

Company number 13146729

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
23 Jan 2024 CS01 Confirmation statement made on 20 January 2024 with updates
23 Dec 2023 AA Accounts for a small company made up to 31 March 2023
06 Oct 2023 AP01 Appointment of Ms Emma Carys Price as a director on 6 October 2023
06 Oct 2023 TM01 Termination of appointment of Mark Craig as a director on 6 October 2023
08 May 2023 TM01 Termination of appointment of Martin William Gordon Palmer as a director on 26 April 2023
08 May 2023 AP01 Appointment of Ms Caterina Musgrave Juer as a director on 26 April 2023
30 Jan 2023 CS01 Confirmation statement made on 20 January 2023 with updates
19 Dec 2022 AA Accounts for a small company made up to 31 March 2022
12 Oct 2022 AD01 Registered office address changed from Suite 1 3rd Floor 11-12 st James's Square London SW1Y 4LB United Kingdom to 7th Floor 50 Broadway London SW1H 0DB on 12 October 2022
15 Aug 2022 AP01 Appointment of Martin William Gordon Palmer as a director on 5 August 2022
12 Aug 2022 TM01 Termination of appointment of Sunil Masson as a director on 5 August 2022
22 Apr 2022 PSC02 Notification of Roivant Sciences Ltd. as a person with significant control on 1 October 2021
22 Apr 2022 PSC09 Withdrawal of a person with significant control statement on 22 April 2022
08 Mar 2022 CERTNM Company name changed pharmavant 7 holdings LIMITED\certificate issued on 08/03/22
  • NM01 ‐ Change of name by resolution
  • RES15 ‐ Change company name resolution on 2022-03-07
20 Jan 2022 CS01 Confirmation statement made on 20 January 2022 with updates
25 Jan 2021 AD01 Registered office address changed from First Floor, Templeback 10 Temple Back Bristol BS1 6FL United Kingdom to Suite 1 3rd Floor 11-12 st James's Square London SW1Y 4LB on 25 January 2021
20 Jan 2021 AA01 Current accounting period extended from 31 January 2022 to 31 March 2022
20 Jan 2021 NEWINC Incorporation
Statement of capital on 2021-01-20
  • USD 20,560